Skip to content

13F-HR filed by SECTOR GAMMA AS

SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2016-06-30, filed 2016-08-11, with 24 holding rows worth $494,142,000.

Accession
0001475373-16-000005
Filed
2016-08-11
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2016

A holdings report, 24 entries on the cover page, a total value of $494,142,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $494,142,000 with VALUE read as thousands by filing date, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Eli Lilly and Company532457108COM914,920$72,050,000thousands by filing date
BAXTER INTL INC071813109COM1,078,943$48,790,000thousands by filing date
Boston Scientific Corporation101137107COM1,412,170$33,002,000thousands by filing date
REVVITY INC714046109COM543,710$28,501,000thousands by filing date
SHIRE PLC82481R106COMMON STOCK-FO152,386$28,051,000thousands by filing date
INTEGRA LIFESCIENCES HLDGS C457985208COM NEW329,657$26,300,000thousands by filing date
BIOGEN INC COM09062X103Stock96,690$23,382,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK1,769,368$23,134,000thousands by filing date
ST JUDE MED INC790849103COM258,214$20,141,000thousands by filing date
PATTERSON COS INC703395103COM416,844$19,963,000thousands by filing date
MASIMO CORP COM574795100Stock352,053$18,488,000thousands by filing date
BIO RAD LABS INC090572207CL A129,124$18,467,000thousands by filing date
Abbott Laboratories002824100COM436,200$17,147,000thousands by filing date
EXELIXIS INC COM30161Q104Stock2,059,833$16,087,000thousands by filing date
MCKESSON CORP COM58155Q103Stock79,020$14,749,000thousands by filing date
Merck & Co.,Inc.58933Y105COM247,650$14,267,000thousands by filing date
CIGNA CORPORATION125509109COM109,870$14,062,000thousands by filing date
Bristol-Myers Squibb Company110122108COM187,500$13,791,000thousands by filing date
Elevance Health, Inc.036752103COM104,300$13,699,000thousands by filing date
MOMENTA PHARMACEUTICALS INC60877T100COM914,979$9,882,000thousands by filing date
ACCENDRA HEALTH INC690732102COM202,342$7,564,000thousands by filing date
IMPAX LABORATORIES INC45256B101COM233,934$6,742,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock195,300$5,398,000thousands by filing date
SPECTRUM PHARMACEUTICALS INC84763A108COM73,810$485,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001475373-16-000005this filing2016-08-11acceptance time not in the bulk data set
13F-HR/A 0001475373-17-000004 added2017-03-03acceptance time not in the bulk data set